Company Filing History:
Years Active: 2004-2007
Title: Royal J Haskell: Innovator in Pharmaceutical Compositions
Introduction
Royal J Haskell is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target cyclooxygenase-2 mediated conditions. With a total of 2 patents, Haskell's work has the potential to impact therapeutic practices significantly.
Latest Patents
Haskell's latest patents include innovative pharmaceutical compositions that comprise selective cyclooxygenase-2 inhibitory drugs. These drugs are characterized by low water solubility and are designed to provide a rapid onset of therapeutic effect. The compositions are particularly advantageous for treating conditions where quick relief is necessary. Another patent focuses on a laboratory scale milling process that effectively reduces the particle size of drugs. This process involves creating a suspension of the drug in a liquid medium, followed by a series of steps to achieve a weight average particle size of about 1 µm.
Career Highlights
Throughout his career, Haskell has worked with prominent companies in the pharmaceutical industry, including Pharmacia Corporation and Pharmacia & Upjohn Company. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Haskell has collaborated with notable colleagues such as Tugrul T Kararli and Mark Kontny. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Royal J Haskell's contributions to pharmaceutical innovations demonstrate his commitment to improving therapeutic outcomes. His patents reflect a deep understanding of drug formulation and the importance of rapid therapeutic effects. Haskell's work continues to influence the field of pharmaceuticals positively.